ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Outcomes following myocardial revascularization: on and off cardiopulmonary bypass

This study is currently recruiting patients.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs

Purpose

Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in FY 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest ("on-pump") and the other without CPB on a beating heart ("off-pump"). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.

Condition Treatment or Intervention Phase
Ischemic Heart Disease
 Procedure: Coronary artery bypass - on-pump
 Procedure: Coronary artery bypass - off-pump
Phase III

MedlinePlus related topics:  Circulatory Disorders;   Heart Diseases;   Heart Diseases--Prevention

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study

Official Title: CSP #517 - Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

Further Study Details: 

Expected Total Enrollment:  2200

Study start: April 2002;  Expected completion: April 2007

Primary Hypotheses: The study has two primary hypotheses to evaluate the impact of using an off-pump versus an on-pump surgical technique for CABG procedures. One is a short term objective to assess the immediate impact of the two surgical techniques while the second assesses the long-term impact of the two techniques: 1) Short-Term Null Hypothesis: For patients having CABG-only procedures performed, there will be no difference in the short-term composite clinical outcome (30 day death or major morbidity) between patients randomized to the on-pump and off-pump procedures, 2) Long-Term Null Hypothesis: For patients undergoing CABG-only procedures, there will be no difference in long-term clinical outcome as measured by one year mortality and/or acute myocardial infarction prior to one year and/or a subsequent revascularization procedure within one year between patients randomized to the on-pump and off-pump procedures.

Secondary Hypotheses: Major secondary objectives are to determine if there are differences in patients undergoing CABG-only procedures using the on-pump and off-pump techniques for 1) long-term completeness of revascularization, 2) one year graft patency and stenosis rates as determined by angiography at one year, and 3) short-term completeness of revascularization. Other secondary objectives are to evaluate the two surgical techniques on 1) changes in neuropsychological function, 2) traditional clinical outcomes, 3) general and disease specific quality of life, and 4) useof system resources.

Intervention: Patients requiring an elective or urgent CABG-only (no other procedures to be done) surgical procedure will be randomized to either the off-pump procedure or to the on-pump procedure.

Primary Outcomes: The short-term primary outcome measure is a composite measure of death, repeat cardiac surgery, new technical support, cardiac arrest, coma, prolonged stroke and/or renal failure requiring dialyses occurring within 30 days of surgery or prior to discharge, whichever is latest. The long-term primary outcome measure is a composite of death, acute myocardial infarction, and/or subsequent revascularization procedure prior to one year post-surgery.

Study Abstract: Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in FY 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest ("on-pump") and the other without CPB on a beating heart ("off-pump"). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.

Eligibility

Genders Eligible for Study:  Both

Criteria


Location and Contact Information


California
      Vamc - Palo Alto, Ca, Palo Alto,  California,  94304,  United States; Recruiting
John Giacomini, M.D.  650-493-5000  Ext. 65305    john.giacomini@med.va.gov 

      Vamc - San Francisco, Ca, San Francisco,  California,  94121,  United States; Recruiting
Mark Ratcliffe, M.D.  415-221-4810  Ext. 3451    mark.radcliffe@med.va.gov 

      Vamc - Los Angeles, Ca, Los Angeles,  California,  900073,  United States; Recruiting
Edward Livingston, MD  310-268-3525    edward.livingston@med.va.gov 

Colorado
      Vamc - Denver, Co, Denver,  Colorado,  80220,  United States; Recruiting
Joseph Cleveland, Jr., M.D.  303-266-3855    joseph.cleveland@uchsc.edu 

District of Columbia
      Vamc - Washington, Dc, Washington,  District of Columbia,  20422,  United States; Recruiting
Pendleton Alexander, M.D.  202-745-8626    epalexander@med.va.gov 

Florida
      Vamc - Miami, Fl, Miami,  Florida,  33125,  United States; Recruiting
Richard J Thurer, MD  305-324-4455  Ext. 3244    richard.thurer@med.va.gov 

      Vamc - Gainesville, Fl, Gainesville,  Florida,  32608,  United States; Recruiting
Felipe Urdaneta, MD  352-376-1611  Ext. 6013 

      Vamc - Tampa, Fl, Tampa,  Florida,  33612,  United States; Recruiting
Dimitri Novitzky, M.D.  813-259-0626    dimitri.novitzky@med.va.gov 

New Mexico
      Vamc - Albuquerque, Nm, Albuquerque,  New Mexico,  87108,  United States; Recruiting
Sarah Vernon, MD  505-265-1711    sarah.vernon@med.va.gov 

North Carolina
      Vamc - Asheville, Nc, Asheville,  North Carolina,  28805,  United States; Recruiting
John Lucke, M.D.  828-281-6024    john.lucke@med.va.gov 

Ohio
      Vamc - Cleveland, Oh, Cleveland,  Ohio,  44106,  United States; Recruiting
Diana Whittlesey, M.D.  216-791-3800  Ext. 4288    diana.whittlesey@med.va.gov 

Oregon
      Vamc - Portland, Or, Portland,  Oregon,  97201,  United States; Suspended

Pennsylvania
      Vamc - Pittsburgh, Pa, Pittsburgh,  Pennsylvania,  15213,  United States; Recruiting
Ali M Sonel, MD  412-688-6000  Ext. 5863    ali.sonel@med.va.gov 

Texas
      Vamc - Dallas, Tx, Dallas,  Texas,  75216,  United States; Recruiting
Philip Greilich, MD  214-857-1817    philip.greilich@med.va.gov 

      Vamc - San Antonio, Tx, San Antonio,  Texas,  78284,  United States; Recruiting
Gregory Freeman, MD  210-617-5300    gregory.freeman@med.va.gov 

Wisconsin
      Vamc - Milwaukee, Wi, Milwaukee,  Wisconsin,  53226,  United States; Recruiting
Hossein Almassi, M.D.  414-557-8444    galmassi@mcw.edu 

More Information

Study ID Numbers:  517
Record last reviewed:  January 2004
Record first received:  March 27, 2002
ClinicalTrials.gov Identifier:  NCT00032630
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-19
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act